[6-K] PURPLE BIOTECH LTD. Current Report (Foreign Issuer)
Purple Biotech Ltd. (PPBT) furnished a Form 6-K reporting that on October 20, 2025 it issued a press release titled “Purple Biotech Announces Receipt of Nasdaq Regarding Minimum Bid Price Notification.”
The press release is included as Exhibit 99.1. This filing serves as a notice to investors about the company’s receipt of a Nasdaq minimum bid price notification and provides the related disclosure via the attached exhibit.
Purple Biotech Ltd. (PPBT) ha fornito un modulo 6-K riferita che il 20 ottobre 2025 ha emesso un comunicato stampa intitolato “Purple Biotech Announces Receipt of Nasdaq Regarding Minimum Bid Price Notification.”
Il comunicato stampa è incluso come Exhibit 99.1. Questo deposito funge da avviso agli investitori riguardo alla ricezione da parte dell'azienda di una notifica sul prezzo minimo di Nasdaq e fornisce la relativa divulgazione tramite l’esibizione allegata.
Purple Biotech Ltd. (PPBT) presentó un Formulario 6-K que comunica que el 20 de octubre de 2025 emitió un comunicado de prensa titulado “Purple Biotech Announces Receipt of Nasdaq Regarding Minimum Bid Price Notification.”
El comunicado de prensa se incluye como Exhibit 99.1. Este archivo sirve como aviso a los inversionistas sobre la recepción por parte de la empresa de una notificación de precio mínimo de Nasdaq y proporciona la divulgación relacionada a través del exhibit adjunto.
Purple Biotech Ltd. (PPBT)은 2025년 10월 20일에 Nasdaq의 최저 입찰가 고지에 대한 수신에 관한 보도자료를 발행했다고 보고하는 Form 6-K를 제출했습니다. 제목은 “Purple Biotech Announces Receipt of Nasdaq Regarding Minimum Bid Price Notification.”
해당 보도자료는 Exhibit 99.1로 포함되어 있습니다. 이 제출은 투자자에게 Nasdaq 최소 호가 고지 수신에 대한 회사의 공지를 제공하며 첨부 전시를 통해 관련 공시를 제공합니다.
Purple Biotech Ltd. (PPBT) a fourni un formulaire 6-K indiquant que le 20 octobre 2025, il a publié un communiqué de presse intitulé « Purple Biotech Announces Receipt of Nasdaq Regarding Minimum Bid Price Notification ».
Le communiqué de presse est inclus en tant que Exhibit 99.1. Cette dépôt sert d'avis aux investisseurs concernant la réception par la société d'une notification du Nasdaq concernant le prix d'offre minimum et fournit la divulgation associée via l'exhibit ci-joint.
Purple Biotech Ltd. (PPBT) legte ein Form 6-K vor, das berichtet, dass am 20. Oktober 2025 eine Pressemitteilung mit dem Titel „Purple Biotech Announces Receipt of Nasdaq Regarding Minimum Bid Price Notification“ veröffentlicht wurde.
Die Pressemitteilung ist als Exhibit 99.1 enthalten. Diese Einreichung dient Investoren als Mitteilung über den Erhalt einer Nasdaq-Bodenpreismanache und bietet die entsprechenden Offenlegungen über das beigefügte Exhibit.
Purple Biotech Ltd. (PPBT) قدمت نموذج 6-K يُشير إلى أنه في 20 أكتوبر 2025 أصدرت بياناً صحفياً بعنوان “Purple Biotech Announces Receipt of Nasdaq Regarding Minimum Bid Price Notification.”
يُدرج البيان الصحفي كـ Exhibit 99.1. هذا الإيداع بمثابة إشعار للمستثمرين بتلقي الشركة لإشعار سعر العرض الأدنى من ناسداك ويوفر الإفصاح المتعلق من خلال المعروض المرفق.
Purple Biotech Ltd. (PPBT) 已提交 Form 6-K，披露其在 2025 年 10 月 20 日发布了一则题为“Purple Biotech Announces Receipt of Nasdaq Regarding Minimum Bid Price Notification”的新闻稿。
新闻稿被列为 Exhibit 99.1。本次 filing 作为对投资者的通知，说明公司收到 Nasdaq 的最低成交价格通知，并通过附带的展品提供相关披露信息。
- None.
- None.
Purple Biotech Ltd. (PPBT) ha fornito un modulo 6-K riferita che il 20 ottobre 2025 ha emesso un comunicato stampa intitolato “Purple Biotech Announces Receipt of Nasdaq Regarding Minimum Bid Price Notification.”
Il comunicato stampa è incluso come Exhibit 99.1. Questo deposito funge da avviso agli investitori riguardo alla ricezione da parte dell'azienda di una notifica sul prezzo minimo di Nasdaq e fornisce la relativa divulgazione tramite l’esibizione allegata.
Purple Biotech Ltd. (PPBT) presentó un Formulario 6-K que comunica que el 20 de octubre de 2025 emitió un comunicado de prensa titulado “Purple Biotech Announces Receipt of Nasdaq Regarding Minimum Bid Price Notification.”
El comunicado de prensa se incluye como Exhibit 99.1. Este archivo sirve como aviso a los inversionistas sobre la recepción por parte de la empresa de una notificación de precio mínimo de Nasdaq y proporciona la divulgación relacionada a través del exhibit adjunto.
Purple Biotech Ltd. (PPBT)은 2025년 10월 20일에 Nasdaq의 최저 입찰가 고지에 대한 수신에 관한 보도자료를 발행했다고 보고하는 Form 6-K를 제출했습니다. 제목은 “Purple Biotech Announces Receipt of Nasdaq Regarding Minimum Bid Price Notification.”
해당 보도자료는 Exhibit 99.1로 포함되어 있습니다. 이 제출은 투자자에게 Nasdaq 최소 호가 고지 수신에 대한 회사의 공지를 제공하며 첨부 전시를 통해 관련 공시를 제공합니다.
Purple Biotech Ltd. (PPBT) a fourni un formulaire 6-K indiquant que le 20 octobre 2025, il a publié un communiqué de presse intitulé « Purple Biotech Announces Receipt of Nasdaq Regarding Minimum Bid Price Notification ».
Le communiqué de presse est inclus en tant que Exhibit 99.1. Cette dépôt sert d'avis aux investisseurs concernant la réception par la société d'une notification du Nasdaq concernant le prix d'offre minimum et fournit la divulgation associée via l'exhibit ci-joint.
Purple Biotech Ltd. (PPBT) legte ein Form 6-K vor, das berichtet, dass am 20. Oktober 2025 eine Pressemitteilung mit dem Titel „Purple Biotech Announces Receipt of Nasdaq Regarding Minimum Bid Price Notification“ veröffentlicht wurde.
Die Pressemitteilung ist als Exhibit 99.1 enthalten. Diese Einreichung dient Investoren als Mitteilung über den Erhalt einer Nasdaq-Bodenpreismanache und bietet die entsprechenden Offenlegungen über das beigefügte Exhibit.
FAQ
What did Purple Biotech (PPBT) file?
What is the subject of the PPBT 6-K?
When was the press release issued by PPBT?
What is included as an exhibit in this filing?
What is Purple Biotech’s ticker symbol?
